Effects of tibolone on endogenous nitric oxide (nitrite/nitrate levels) in postmenopausal women.
To observe the effects of hormone replacement therapy with 2.5 mg/day tibolone for 6 months upon plasma nitrite/nitrate (end products of nitric oxide metabolism) in postmenopausal women. The study involved 24 healthy postmenopausal women treated with tibolone (2.5 mg/day for 6 months) and 20 postmenopausal women who received placebo. Plasma nitrite/nitrate levels were measured with the Griess reaction. Statistical significance was analyzed by the Mann-Whitney U test and Pearson correlation analysis. The mean baseline concentrations of nitrite/nitrate were similar in both treated and placebo groups. Tibolone treatment decreased plasma nitrite/nitrate levels. We suggest that because of its androgenic and progestogenic actions, tibolone diminishes nitrite/nitrate levels. Also our data provide evidence for the existence of increased (1/3 of subjects, n = 8) and reduced (2/3 of subjects, n = 16) nitrite/nitrate levels in response to tibolone treatment. Clearly, further studies are necessary to establish a risk/benefit ratio for tibolone in view of its effects on nitric oxide metabolism.